Pharmaceuticals & Biotechnology Editor | 03/25/2010
Eli Lilly and Co. is a leader in researching and developing pharmaceutical-based healthcare solutions that enable patients to live longer, healthier and more active lives. In the five years from 2001 to 2005, when FDA approved nearly 40 percent fewer new molecular entities than it did in the preceding five-year period, Lilly has launched nine new products.
Download PDF Attachment
RECOMMENDED
Upcoming Events
DigIT Pharma 2026 | AI Commercial, Medical & Patient Care
September 9 - 10, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More
Pharmaceutical Launch Excellence Summit US
September 30 - October 1 2026
Hyatt Regency Boston Harbor, Boston, US
Register Now |
View Agenda |
Learn More